XM tillhandahåller inte tjänster till personer bosatta i USA.

Procter & Gamble set to report tepid revenue growth



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>PREVIEW-Procter & Gamble set to report tepid revenue growth</title></head><body>

By Jessica DiNapoli and Ananya Mariam Rajesh

NEW YORK, Oct 16 (Reuters) -Procter & Gamble PG.N is set to report muted quarterly revenue growth on Friday. The purveyor of Tide detergent, Dawn dish soap and Pampers diapers faces rivals competing on price in its two biggest markets, the United States and China.

Chief Financial Officer Andre Schulten said on Sept. 5 at an investor conference the consumer products company's first quarter, which ended Sept. 30, would "not look materially different" from the prior quarter. In its fourth quarter ended June 30, sales were flat and organic sales rose 2%. Organic sales do not count the impacts of foreign exchange, acquisitions and divestitures.

The Cincinnati-based company, considered a bellwether for American consumers broadly, is seeing a slowdown in growth in its biggest market, the United States. P&G executives have said it offers products for nearly every price point and across retailers, from Walmart WMT.N to Costco COST.O.

Brian Mulberry, client portfolio manager at Zacks Investment Management, which has a stake in P&G, said the company has not reduced prices in recent months, leading to "weaker demand and slowing sales."

P&G also has expanded its distribution to dollar stores such as Dollar Tree DLTR.O to broaden its market share among low-income Americans earning less than $35,000 per year. But many are paring back their spending or turning to retailers' own-brand private-label products.

P&G is "giving a huge opening to a lot of private label, like (Costco's) Kirkland Signature and Vons, to really get embedded into households and improve over time," said Michael Schulman, chief investment officer at P&G investor Running Point Capital. Supermarket operator Albertsons ACI.N owns Vons, a grocery chain with locations in California and Nevada.

"I think they're missing out on lower-income consumers. And what they risk there is huge," Schulman added.

Christian Greiner, senior portfolio manager at F/m Investments, which holds P&G shares, said P&G would have to lower prices by discounting in order to significantly boost U.S. volumes, a move that could hurt its profitability.

P&G's first-quarter net sales are expected to rise 0.35% to $21.95 billion, according to estimates compiled by LSEG. The company is expected to post quarterly adjusted profit per share of $1.90, compared to the $1.83 it reported a year earlier.

P&G has forecast fiscal year 2025 all-in sales to grow 2% to 4% and core profit per share to be between $6.91 and $7.05.

"I'm not expecting any great shakes from them" on Friday, Schulman said.

According to NielsenIQ data in a research note from Bernstein, P&G's overall market share has been roughly flat the past two months, as has its share in fabric and home care, its biggest business. Unilever ULVR.L, which makes rival products including Persil detergent, isoverhauling the supply chain for its home care business in Europe, and plans to boost its own promotions in the category.

In P&G's second biggest market, China, many shoppers are rejecting its pricey SK-II face serums. Weak consumer spending in China overall makes any U.S. revenue growth increasingly important, said Michelle Li, an analyst at Parnassus Investments.

CEO Jon Moeller said at the company's annual meeting on Oct. 8 that tensions in the Middle East have had an impact on P&G's business. Pro-Palestinian activists have called for consumers to boycott the company because of its connections to Israel. The company has offices in Tel Aviv and says its products such as Pantene shampoo are in 98% of Israeli households.


Unit growth at consumer goods companies in 2024 https://reut.rs/3Y6hVYP


Reporting by Jessica DiNapoli in New York and Ananya Mariam Rajesh in Bengaluru; Editing by Chris Reese

</body></html>

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.